Konstantinos Leventogiannis, Evdoxia Kyriazopoulou, Nikolaos Antonakos, Antigone Kotsaki, Iraklis Tsangaris, Dimitra Markopoulou, Inge Grondman, Nikoleta Rovina, Vassiliki Theodorou, Eleni Antoniadou, Ioannis Koutsodimitropoulos, George Dalekos, Glykeria Vlachogianni, Karolina Akinosoglou, Vassileios Koulouras, Apostolos Komnos, Theano Kontopoulou, Athanassios Prekates, Antonia Koutsoukou, Jos WM van der Meer, George Dimopoulos, Miltiades Kyprianou, Mihai G Netea, Evangelos J. Giamarellos-Bourboulis

Τoward personalized immunotherapy in sepsis the PROVIDE randomized clinical trial

Cell Reports Medicine 2022 Nov 15;3(11):100817
DOI: 10.1016/j.xcrm.2022.100817Download pdf 🡇

Funding

The study was supported in part by the Hellenic Institute for the Study of Sepsis, in part by bioMérieux, Lyon, France, and in part by a Spinoza grant of the Netherlands Organisation for Scientific Research (to M.G.N.).

Keywords: macrophage activation; immunoparalysis; sepsis; ferritin; mortality; monocytes
Realted Study: PROVIDE